ADC Therapeutics SA (NYSE:ADCT) Q3 2023 Earnings Call Transcript

Operator: Welcome to the ADC Therapeutics Third Quarter 2023 Financial Results Conference Call. My name is Cathy and I will be your operator for today's call.

Keep Reading →